These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 495639)

  • 21. Aminoglycosides against carbapenem-resistant Enterobacteriaceae in the critically ill: the pitfalls of aminoglycoside susceptibility.
    Zavascki AP; Klee BO; Bulitta JB
    Expert Rev Anti Infect Ther; 2017 Jun; 15(6):519-526. PubMed ID: 28375030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enterobacter aerogenes pneumopathy treated by a cefepime-sulbactam-gentamicin combination].
    Mardrus P; Le Grand JL; Chardon H; Garrigues B
    Presse Med; 1998 May 2-9; 27(17):804-5. PubMed ID: 9767884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
    Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
    Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissemination of Genes Encoding Aminoglycoside-Modifying Enzymes and armA Among Enterobacteriaceae Isolates in Northwest Iran.
    Ghotaslou R; Yeganeh Sefidan F; Akhi MT; Asgharzadeh M; Mohammadzadeh Asl Y
    Microb Drug Resist; 2017 Oct; 23(7):826-832. PubMed ID: 28151044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion.
    Miró E; Grünbaum F; Gómez L; Rivera A; Mirelis B; Coll P; Navarro F
    Microb Drug Resist; 2013 Apr; 19(2):94-9. PubMed ID: 23206280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
    Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G
    Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five-year surveillance of aminoglycoside usage in a university hospital.
    Betts RF; Valenti WM; Chapman SW; Chonmaitree T; Mowrer G; Pincus P; Messner M; Robertson R
    Ann Intern Med; 1984 Feb; 100(2):219-22. PubMed ID: 6691664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
    Ronco E; Migueres ML; Vacheron F; Guenounou M
    Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin].
    Jarlier V; Philippon A; Nicolas MH; Bismuth R; Paul G; Fusciardi J
    Pathol Biol (Paris); 1984 May; 32(5):399-403. PubMed ID: 6739148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.
    Jacobson KL; Cohen SH; Inciardi JF; King JH; Lippert WE; Iglesias T; VanCouwenberghe CJ
    Clin Infect Dis; 1995 Nov; 21(5):1107-13. PubMed ID: 8589129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.
    Orsini JA; Benson CE; Spencer PA; Van Miller E
    Am J Vet Res; 1989 Jun; 50(6):923-5. PubMed ID: 2669575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
    Maraki S; Vardakas KZ; Samonis G; Perdikis D; Mavromanolaki VE; Kofteridis DP; Falagas ME
    Future Microbiol; 2017 Jun; 12():683-693. PubMed ID: 28540747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five cases of high-level aminoglycoside resistant enterococcal septicaemia in Singapore.
    Chiew YF
    Singapore Med J; 1994 Apr; 35(2):177-9. PubMed ID: 7939816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of procedural variations on the activity of aminoglycosides in vitro.
    Sanders CC; Sanders WE
    Am J Clin Pathol; 1975 Mar; 63(3):438-45. PubMed ID: 1119441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.